GSK3B and hepatocellular carcinoma: These results provide some insight into the ability of erinacine to inhibit the growth and progression of HCC and implicate [Ca2+]cyt, [Ca2+]MT, the mitochondrial permeability pore transition and the components of the PI3kinase/Akt/GSK-3β pathway in the mechanism of erinacine action.